WASHINGTON, D.C. — Georgetown University Medical Center (GUMC) has licensed worldwide rights of a potential novel cancer therapy and diagnostic, or "theranostic," to BioMetrx, LLC. The agent was ...

Adams-Campbell, PhD, associate director for minority health and health disparities research, and professor of oncology at Georgetown University Medical Center's Lombardi Comprehensive Cancer Center.

The CDD is a translational medicine initiative made possible by the award of a Chemical Diversity Center grant from the National Cancer Institute (NCI) and membership in the NCI Chemical Biology ...

Georgetown University Medical Center announces the launch of the only known therapeutic (disease modifying) clinical trial for Lewy body dementia, a neurological disorder that affects a million ...

Georgetown University Medical Center (GUMC) has licensed worldwide rights of a potential novel cancer therapy and diagnostic, or "theranostic," to BioMetrx, LLC. The agent was invented by two ...